Physician profile
Niraj Nayan Desai
NPI 1508048802
$128,642.10
in general payments reported to CMS, 2019-2025
25 companies · $30K in 2025
The $30K reported for 2025 was more than what 97% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,347 · 2020: $1,413 · 2021: $7,032 · 2022: $13K · 2023: $29K · 2024: $44K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $98K · Food and Beverage: $4,236 · Travel and Lodging: $840 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $263 · Honoraria: $27.78 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $97,533.14 |
| Food and Beverage | $4,235.78 |
| Travel and Lodging | $840.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $262.50 |
| Honoraria | $27.78 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $118,178.67 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Whitestar Signature Pro |
| Biotissue Holdings INC. | $3,974.20 | 2019-2025 | |
| Glaukos Corporation | $2,514.54 | 2019-2024 | Idose, Kxl System (Not Refurbished) |
| Alcon Vision LLC | $1,017.15 | 2021-2025 | Clareon, Hydrus Microstent, Luxor |
| Rxsight INC | $460.57 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Eyepoint US, INC. | $278.30 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $275.42 | 2020-2023 | |
| New World Medical,INC. | $269.48 | 2019-2025 | Via360, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Bausch & Lomb Americas INC. | $163.51 | 2023-2025 | Miebo, Vyzulta, Envista Aspire Iol |
| Sight Sciences, INC. | $160.08 | 2022-2023 | Omni Surgical System |
| Amgen INC. | $155.90 | 2024-2025 | Tepezza |
| Genentech USA, INC. | $150.00 | 2025 | Susvimo |
| Tarsus Pharmaceuticals, INC. | $143.13 | 2025 | Xdemvy |
| Horizon Therapeutics Plc | $141.66 | 2021-2023 | Tepezza |
| Allergan, INC. | $137.21 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $127.98 | 2022 | |
| Dompe US, INC. | $103.44 | 2019-2021 | |
| Oyster Point Pharma, INC. | $101.49 | 2022-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $69.80 | 2019 | |
| Sun Pharmaceutical Industries INC. | $67.82 | 2022-2024 | |
| Harrow Eye, LLC | $60.93 | 2024-2025 | Vevye |
| Akorn Operating Company LLC | $31.67 | 2021 | |
| Mallinckrodt Hospital Products INC. | $24.50 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.38 | 2025 | Ultomiris |
| Kala Pharmaceuticals, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Niraj Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.